loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 2492393 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    F. Hoffmann-La Roche

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ATEZOLIZUMAB (1)

    filter

    01 HOFFMANN-LA ROCHE LIMITED (1)

    filter

    01 SOLUTION (1)

    filter

    01 840MG/14ML (1)

    filter

    01 Canada (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Atezolizumab

    PDF Supplier PDF
    URL Supplier Web Content
    SOLUTION
    840MG/14ML
    TECENTRIQ
    Canada
    2492393
    Prescription
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 2492393

    Looking for CTD TGA MCC DOSSIER APPLICATION 2492393 1

    19

    F. Hoffmann-La Roche, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is ATEZOLIZUMAB, with a corresponding application number 2492393 and regulatory information .

    proudly manufactured in the

    F. Hoffmann-La Roche's TECENTRIQ SOLUTION, medication with 840MG/14ML of ATEZOLIZUMAB.

    Post Enquiry
    POST ENQUIRY